Eidelman Virant Capital Bristol Myers Squibb CO Transaction History
Eidelman Virant Capital
- $136 Million
- Q3 2022
A detailed history of Eidelman Virant Capital transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Eidelman Virant Capital holds 41,275 shares of BMY stock, worth $1.94 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
41,275
Previous 41,275
-0.0%
Holding current value
$1.94 Million
Previous $3.04 Million
2.46%
% of portfolio
2.18%
Previous 2.18%
Shares
9 transactions
Others Institutions Holding BMY
# of Institutions
2,806Shares Held
1.59BCall Options Held
25.9MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.46 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.08 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.46 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.12 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.9B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...